Transforming Cardiovascular Care
Viz.ai and Cleerly have joined forces to improve early detection and management of heart disease, a leading global health threat. This partnership integrates Cleerly’s advanced AI diagnostic tools into Viz.ai’s One platform, aiming to streamline care coordination for patients at risk of heart disease. The goal is to enable faster diagnosis and treatment, ultimately enhancing patient outcomes.
Key Highlights
- Cleerly’s innovative software utilizes AI algorithms on CCTA images to detect heart disease.
- The Viz.ai One platform now includes advanced features like ECG AI and chest CT visualization.
- The collaboration aims to facilitate timely referrals to specialists, improving access to vital treatments.
- Clinicians in over 1,600 hospitals will benefit from this integration, enhancing their ability to detect coronary artery disease early.
Importance of the Partnership
This collaboration represents a significant advancement in cardiovascular care. By merging cutting-edge technologies, it empowers healthcare providers to deliver personalized treatment plans based on precise diagnostics. The integration of these platforms is expected to lead to earlier detection of heart issues, which is crucial for improving patient survival rates and quality of life. As heart disease remains a leading cause of death, such innovations can transform the landscape of heart health management.
